These data suggest that JP can inhibit the BAFF/BAFF-R signaling pathway, which may be associated with the mechanism of the JP-mediated reduction of GC dosage for the treatment of SLE. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.